The role of CpG in DNA vaccines

Springer Seminars in Immunopathology

Volumn 22, Issue 1-2, 2000, Pages 125-132

  McCluskie, M J ^a   Weeratna, R D ^a   Davis, H L ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN GROWTH HORMONE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; CYTOTOXIC T LYMPHOCYTE; GENE TARGETING; IMMUNE RESPONSE; IMMUNOSTIMULATION; PLASMID; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0033749407     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002810000014     Document Type: Review

References (63)

1. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice
2. Induction of HIV-1 specific mucosal immune responses by DNA vaccination
3. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
4. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
5. Liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
6. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
7. DNA-based immunization by in vivo transfection of dendritic cells
8. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA
9. DNA vaccines for viral diseases
10. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
11. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes
12. Immunoadjuvant action of plasmid DNA in liposomes
13. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α
14. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter
15. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
16. The pathology of asthma
17. Immunostimulatory DNA is a potent mucosal adjuvant
18. Transcriptional repression by methylation: Cooperativity between a CpG cluster in the promoter and remote CpG-rich regions
19. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1
20. Myoblast transfer in Duchenne muscular dystrophy
21. TH2-type cytokines in asthma
22. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts
23. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
24. Contribution of CpG motifs to the immunogenicity of DNA vaccines
25. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
26. Human gene therapy for hereditary diseases: A review of trials
27. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
28. CpG motifs in bacterial DNA trigger direct B-cell activation
29. The role of CpG dinucleotides in DNA vaccines
30. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization
31. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA
32. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung
33. Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations
34. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice
35. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response
36. Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA
37. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice
38. Novel strategies using DNA for the induction of mucosal immunity
39. Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes
40. Myoblast transfer in the treatment of Duchenne's muscular dystrophy
41. Intratracheal gene delivery to the mouse airway: Characterization of plasmid DNA expression and pharmacokinetics
42. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
43. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
44. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and nonhuman primates
45. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses
46. Cytokine inhibition of the hepatitis B virus core promoter
47. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine
48. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes
49. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
50. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung
51. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
52. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device
53. Genetic immunization is a simple method for eliciting an immune response
54. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans
55. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
56. Reduction of antigen expression from DNA vaccines by co-administered oligonucleotides
57. Direct gene transfer into mouse muscle in vivo
58. The effect of interferon-γ on genetic immunization
59. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid: pDNA complexes
60. Optimization of plasmid vectors for high-level expression in lung epithelial cells
61. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway
62. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo
63. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate and mixed phosphorothioate and methylphosphonate oligonucleotides